admin, Author at PsyNews.com

Home Authors Posts by admin

1283 POSTS 0 COMMENTS

https://psynews.com

Australia Recognises MDMA and Psilocybin as Medicines

A Spotlight on Psychedelic Research Methods

Panel: Psychedelic Research Methods

A Perspective from the ‘Reimagining Psychedelic Trials’ Working Group

Historical Insights on the Psychedelic Renaissance

PT386 – Vital Psychedelic Conversations

Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding...

Silo Pharma Announces Expansion of Intellectual Property Portfolio

PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX™...

Ehave Provides Progress Update on its HPPD Study with University of...

12 3...129 Page 1 of 129

Psychedelic Bulletin #130: Australia to Reschedule MDMA and Psilocybin; Small Pharma...

Psychedelics Weekly – Research Explained: Ketamine and the Corticothalamic Network, Psilocybin...

Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin